# Amit Shafrir, Angel Investor

Investor in Washington, District Of Columbia

## About Amit Shafrir, Angel Investor

Amit Shafrir is a global President, CEO, COO, entrepreneur, and angel investor.

He is a global leader who specializes in driving organizational growth, scaling companies from 20 to 500 employees, from $20MM to $500MM. His experience spans numerous industries, including Consumer Internet, Mobile, Saas, Senior Care Tech, Media, Healthcare Tech, Medical Devices, Social Good, and Telecom.

He currently serves as the President for the United States at Zoll Itamar, a medical device company and manufacturer focused on leading the integration of Sleep Apnea management into the cardiac patient care pathway.

He is also a Co-founder and Board Member of Quiv, a platform that connects users with experts, enabling them to ask questions, in return for a charitable donation to the expert's cause.

He’s also an angel investor in the seed and early series rounds. Some of his investments are in Bloom, Zipline, Palate Club, and NickNack.

## People

- **Amit Shafrir**, Angel Investor

## Key Facts

- **Location:** Washington, District Of Columbia
- **Investor Type:** Angel Investor

## Investment Industries

- Artificial Intelligence (AI)
- Health and Wellness
- Medical/Healthcare
- Technology/Web/App
- Other

## How to Contact

Direct messaging, this investor's website, and their LinkedIn, Facebook, and X profiles are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/amit-shafrir-angel-investor
- More investors: [AI Investors in District Of Columbia](https://askforfunding.com/site/angel-investors/district-of-columbia/ai)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
